Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
Host: John Buse, MD, PhD
Guest: Anne Louise Peters, MD
SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John Buse about SGLT-2 inhibitors and considerations for diabetic ketoacidosis, heart failure, and chronic kidney disease.
View all episodes
4.3
77 ratings
Host: John Buse, MD, PhD
Guest: Anne Louise Peters, MD
SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John Buse about SGLT-2 inhibitors and considerations for diabetic ketoacidosis, heart failure, and chronic kidney disease.